This product only needs to be tested in one country.Malaria mosquitos are the same everywhere in Africa.
The big buyer would be outfits like the UN/WHO who fund all the various health programs in developing countries.
This drug , Artimist, would be the best solution available if the trials prove up what management believe to be the case, then this will be a big step forward in malaria prevention/treatment and it will have significant value.
The only risk as I see it is ,...Afican country+politicians+United Nations= corruption.Having said that, I think management is up to the task of weaving their way through that minefield.
Occam
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.394M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| EMS (ASX) Chart |
Day chart unavailable